Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma

著录项

• 来源
  《AIDS》 |2017年第6期|共6页
• 作者

  Kraft John C.; McConnachie Lisa A.; Koehn Josefin; Kinman Loren; Collins Carol; Shen Danny D.; Collier Ann C.; Ho Rodney J. Y.;

  展开▼
• 作者单位

  Univ Washington Dept Pharmaceut Seattle WA 98195 USA;

  Univ Washington Dept Pharmaceut Seattle WA 98195 USA;

  Univ Washington Dept Pharmaceut Seattle WA 98195 USA;

  Univ Washington Dept Pharmaceut Seattle WA 98195 USA;

  Univ Washington Dept Pharmaceut Seattle WA 98195 USA;

  Univ Washington Dept Pharmaceut Seattle WA 98195 USA;

  Univ Washington Dept Med Seattle WA USA;

  Univ Washington Dept Pharmaceut Seattle WA 98195 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 传染病;
• 关键词

  drug combination nanoparticles; enhanced and persistent drug exposure; HIV treatment; intracellular HIV drug exposures; long-acting; lopinavir; lymphatic drug insufficiency; lymphatic targeting; targeted drug delivery; tenofovir;

  机译：药物组合纳米粒子;增强和持续的药物暴露;艾滋病毒治疗;细胞内艾滋病毒药物曝光;长效;洛诺维尔;淋巴药物不足;淋巴靶向;靶向药物递送;诱人药物;